When transplanted in NOD/SCID (NS) or NOD/SCID-β2microglobulin−/−(NS-B2M) immunodeficient mice directly after transduction, MLL-AF9-CD34+ cells gave rise to AML, B-ALL, and ABL. This evidence concerns the gene CD34 and acute myeloid leukemia.